Manager TitleAgeSince
Chief Executive Officer 86 01/09/2013
Director of Finance/CFO 55 01/10/2012
Director TitleAgeSince
Chairman 54 12/08/2021
Director/Board Member 45 -
Director/Board Member 54 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-38.68% - - 106K
-1.78%-1.68%+1.48%+15.31% 48.42B
+0.85%-0.70%+460.88%+563.55% 43.66B
-2.40%-0.23%+8.13%+71.41% 39.51B
-2.01%-0.85%+23.85%+8.73% 38.95B
-0.50%+0.85%+20.60%+49.65% 32.61B
+0.38%-3.23% - - 16.32B
-0.59%-2.06%+26.35%+118.09% 16.15B
+0.49%+0.92%+4.11%+23.67% 14.16B
-0.43%+4.70%+78.74%+33.31% 13.37B
Average -0.60%+0.49%+78.02%+110.46% 29.24B
Weighted average by Cap. -0.91%+0.59%+95.83%+132.95%

Financials

2020 2021
Net sales 1.5M 1.74M 1.41M 1.28M 2.41M 166M 2.45M 16.54M 6.47M 83.29M 6.53M 6.39M 277M 1.08M 1.25M 1.01M 921K 1.73M 119M 1.76M 11.86M 4.64M 59.72M 4.68M 4.58M 198M
Net income 14.75M 17.07M 13.86M 12.6M 23.69M 1.63B 24.08M 162M 63.48M 818M 64.1M 62.71M 2.72B -10.57M -12.24M -9.94M -9.04M -16.99M -1.17B -17.27M -116M -45.52M -586M -45.97M -44.97M -1.95B
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33